These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14581560)

  • 1. Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice.
    Nickells M; Chambers TJ
    J Virol; 2003 Nov; 77(22):12232-42. PubMed ID: 14581560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.
    Chambers TJ; Nickells M
    J Virol; 2001 Nov; 75(22):10912-22. PubMed ID: 11602731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model.
    Nickells J; Cannella M; Droll DA; Liang Y; Wold WS; Chambers TJ
    J Virol; 2008 Dec; 82(24):12510-9. PubMed ID: 18842715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain.
    Schlesinger JJ; Chapman S; Nestorowicz A; Rice CM; Ginocchio TE; Chambers TJ
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1277-85. PubMed ID: 8683217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma cell-adapted yellow fever 17D virus: characterization of a viral variant associated with persistent infection and decreased virus spread.
    Vlaycheva LA; Chambers TJ
    J Virol; 2002 Jun; 76(12):6172-84. PubMed ID: 12021351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exchanging the yellow fever virus envelope proteins with Modoc virus prM and E proteins results in a chimeric virus that is neuroinvasive in SCID mice.
    Charlier N; Molenkamp R; Leyssen P; Paeshuyse J; Drosten C; Panning M; De Clercq E; Bredenbeek PJ; Neyts J
    J Virol; 2004 Jul; 78(14):7418-26. PubMed ID: 15220415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.
    Chambers TJ; Liang Y; Droll DA; Schlesinger JJ; Davidson AD; Wright PJ; Jiang X
    J Virol; 2003 Mar; 77(6):3655-68. PubMed ID: 12610141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow fever 17D virus: pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein.
    Vlaycheva L; Nickells M; Droll DA; Chambers TJ
    Virology; 2004 Sep; 327(1):41-9. PubMed ID: 15327896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence.
    Lee E; Lobigs M
    J Virol; 2008 Jun; 82(12):6024-33. PubMed ID: 18400851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice.
    Rumyantsev AA; Murphy BR; Pletnev AG
    J Virol; 2006 Feb; 80(3):1427-39. PubMed ID: 16415020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
    Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
    Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. West Nile 25A virus infection of B-cell-deficient ((micro)MT) mice: characterization of neuroinvasiveness and pseudoreversion of the viral envelope protein.
    Chambers TJ; Droll DA; Walton AH; Schwartz J; Wold WSM; Nickells J
    J Gen Virol; 2008 Mar; 89(Pt 3):627-635. PubMed ID: 18272752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage In vitro is lethal for virus production.
    Lee E; Stocks CE; Amberg SM; Rice CM; Lobigs M
    J Virol; 2000 Jan; 74(1):24-32. PubMed ID: 10590087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
    Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
    Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.
    Hahn CS; Dalrymple JM; Strauss JH; Rice CM
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2019-23. PubMed ID: 3470774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.